Tech Company Financing Transactions

Erasca Funding Round

Erasca, operating out of San Diego, secured $200 million from Arch Venture Partners, Cormorant Asset Management and City Hill Ventures.

Transaction Overview

Company Name
Erasca
Announced On
4/28/2020
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Series B
Investors

Arch Venture Partners (Lead Investor) (Kristina Burow)

Cormorant Asset Management (Lead Investor) (Bihua Chen)

City Hill Ventures

Colt Ventures

Edbi

Invus

LifeSci Venture Partners

Terra Magnum Capital Partners

Proceeds Purpose
Erasca will use the proceeds to support the clinical development of multiple promising oncology programs and further advance the company's in-house drug discovery pipeline.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10835 Rd. to the Cure 140
San Diego, CA 92121
USA
Phone
(858) 465-6511
Website
www.erasca.com
Email Address
[email protected]
Overview
Our mission at Erasca is embedded in our name: To erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology's hardest problems.
Profile
Erasca LinkedIn Company Profile
Social Media
Erasca Company Twitter Account
Company News
Erasca News
Facebook
Erasca on Facebook
YouTube
Erasca on YouTube

Management Team

Title
Name
Email & Social
Chairman
Michael Varney
  Michael Varney LinkedIn Profile  Michael Varney Twitter Account  Michael Varney News  Michael Varney on Facebook
Chief Executive Officer
Jonathan Lim
  Jonathan Lim LinkedIn Profile  Jonathan Lim Twitter Account  Jonathan Lim News  Jonathan Lim on Facebook
Chief Operating Officer
Gary Yeung
  Gary Yeung LinkedIn Profile  Gary Yeung Twitter Account  Gary Yeung News  Gary Yeung on Facebook
General Manager
Jen Majeti
  Jen Majeti LinkedIn Profile  Jen Majeti Twitter Account  Jen Majeti News  Jen Majeti on Facebook
Vice President
Les Brail
  Les Brail LinkedIn Profile  Les Brail Twitter Account  Les Brail News  Les Brail on Facebook
Vice President
Robert Shoemaker
  Robert Shoemaker LinkedIn Profile  Robert Shoemaker Twitter Account  Robert Shoemaker News  Robert Shoemaker on Facebook
Vice President
Jean Vernier
  Jean Vernier LinkedIn Profile  Jean Vernier Twitter Account  Jean Vernier News  Jean Vernier on Facebook
VP - Bus. Development
David Chacko
  David Chacko LinkedIn Profile  David Chacko Twitter Account  David Chacko News  David Chacko on Facebook
VP - Finance
Karen Gilmore
  Karen Gilmore LinkedIn Profile  Karen Gilmore Twitter Account  Karen Gilmore News  Karen Gilmore on Facebook
VP - Operations
David Luo
  David Luo LinkedIn Profile  David Luo Twitter Account  David Luo News  David Luo on Facebook
VP - Regulatory Affairs
Bao Truong
  Bao Truong LinkedIn Profile  Bao Truong Twitter Account  Bao Truong News  Bao Truong on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/28/2020: Templafy venture capital transaction
Next: 4/28/2020: LifeSprout venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to document tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.